Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16997664 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Prevention of Diabetes and Hypertension
Conditions: Diabetes Mellitus;   Hypertension
Interventions: Behavioral: Diet;   Behavioral: Moderate exercise;   Drug: enalapril tablets;   Drug: placebo tablets;   Drug: Losartan Tablets
2 Completed The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
Conditions: Impaired Glucose Tolerance;   Cardiovascular Disease;   Glucose Metabolism Disorders
Interventions: Drug: Ramipril;   Drug: Rosiglitazone

Indicates status has not been verified in more than two years